Actionable news
0
All posts from Actionable news
Actionable news in SRPT: Sarepta Therapeutics, Inc.,

Sarepta Therapeutics's SVP Interim CEO & CMO just disposed of 3,001 shares

Edward M. Kaye, Sarepta Therapeutics's SVP Interim CEO & CMO, recently disposed of 3,001 shares of the company. The disposals took place at $19.71 per share, on April 20, 2016. Kaye still owns 106,028 shares of the company. Kaye operates out of Cambridge, MA. Some additional info was provided as follows:

Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of restricted stock.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Sarepta Therapeutics makes a similar move, sign up!